LAMICTAL
ARIPIPRAZOLE
CARBAMAZEPINE
LITHIUM
OLANZAPINE
QUETIAPINE
RISPERIDONE
SSRI
TOPIRAMATE
VALPROATE
ZIPRASIDONE
LITHIUM
ITALY
Marketing information
Key claims
Country information
United Kingdom
Germany
Spain
Italy
France
References
Supported by GSK.
(c) 2004 Excerpta Medica
All rights reserved.
Disclaimer
Italy
Indication:
For the prevention of manic and depressive recurrences.
Brand name:
Camcolit (Norgine), Liskonum (GSK), Priadel (Sanofi-Synthelabo).
Regulatory status:
Approved.
Launch date:
Not applicable.
